myopic foveoschisis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. High myopia (diopter > -6.0d, axis > 26.5mm) with macular cleavage, myopic macular disease (classification 0- classification 1), and recent significant visual acuity loss or distortion; 2. Myopic macular cleavage with inner or outer macular holes, or macular fovea detachment (T3); 3. Patients aged >=18 years; 4. Able and willing to participate in clinical trials.
Exclusion criteria
Exclusion criteria: 1. Myopic macular cleavage, myopic macular disease (combined with "Plus" damage); 2. myopic macular hole or macular hole retinal detachment; 3. Refractive media opacity seriously affects vision (including severe cataract, corneal leukoplakia, etc); 4. previous vitreoretinal surgery or posterior scleral reinforcement; 5. Visitors are not expected to be in the designated clinical trial center; 6. Having neurological or psychiatric diseases and unable to cooperate with the examination;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| improvement of myopic foveoschisis; | — |
Countries
China
Contacts
The Eye Hospital of Wenzhou Medical University